Discrimination Between Normal and Malignant Breast Tissues by Synchronous Luminescence Spectroscopy
Tatjana Dramićanin,1 Miroslav D. Dramićanin,1* Bogomir Dimitrijević,1 Vukoman Jokanović1 and Silvana Lukić2
1 Institute of Nuclear Sciences “Vinča,” P.O. Box 522, 11001 Belgrade, Serbia, dramican@vin.bg.ac.yu
Absrtract
Studies of fluorescence from endogenous molecules in tissues are common for
applications such as detection or characterization of early disease. Breast
cancer is one of the most common malignant tumor among women and good screening
methods are therefore of considerable interest. We have applied synchronous
luminescence spectroscopy (SLS) to examine specimens of excised breast tissues.
Measurements have been made in the 330 nm to 650 nm range of excitation
wavelengths and constant wavelength interval varying from 30 nm to 120 nm on 21
normal and 21 malignant breast tissue samples. Significant differences between
SLS patterns of normal and malignant tissues are detected and related to the
discrepancy in concentrations of extracellular proteins and co-enzymes.
Malignant tissue identification criteria are established on the basis of
spectral peak areas of SLS spectra that correspond to constant wavelength
intervals where the most pronounced differences are observed. These
characteristic intervals are chosen from the difference of averaged three-dimensional
SLS patterns of normal and malignant breast tissues. Using
observed statistically significant spectral differences as classification
criteria we tested classification success rate of presented SLS method.
Keywords: Breast tumor, synchronous luminescence spectroscopy, cancer diagnosis.